Mikhail Kosiborod, MD, Cardiology, Lake Lotawana, MO, Lee's Summit Medical Center

MikhailKosiborodMD

Cardiology Lake Lotawana, MO

Echocardiography, Preventive Cardiology

Professor of Medicine (Cardiology), Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City School of Medicine

Dr. Kosiborod is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kosiborod's full profile

Already have an account?

Education & Training

  • Yale-New Haven Hospital
    Yale-New Haven HospitalFellowship, Cardiovascular Disease, 2001 - 2004
  • Yale-New Haven Hospital
    Yale-New Haven HospitalResidency, Internal Medicine, 1997 - 2001
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1997

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2005 - 2022
  • KS State Medical License
    KS State Medical License 2005 - 2021
  • CT State Medical License
    CT State Medical License 2000 - 2006
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Drug Choices in Diabetes and Heart Failure Advice for the Practicing Cardiologist 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Summary of the ACC Expert Consensus Decision Pathway on Novel Therapies for CV Risk Reduction in Diabetes 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Changing Paradigm in Cardiovascular Risk Reduction in Diabetes 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Join now to see all

Authored Content

  • ACC CardiaCast: Emerging Data in SGLT2 InhibitorsJune 2018
  • : An Analysis of CVD-REALJune 2018

Press Mentions

  • University Hospitals Cleveland Medical Center Joins the Cardiometabolic Center Alliance as a Key Strategic Partner and Charter Member
    University Hospitals Cleveland Medical Center Joins the Cardiometabolic Center Alliance as a Key Strategic Partner and Charter MemberOctober 16, 2020 11:53
  • DARE-19: Dapagliflozin Could Target Key Mechanisms Activated in COVID-19
    DARE-19: Dapagliflozin Could Target Key Mechanisms Activated in COVID-19August 23, 2020 09:48
  • New-Onset AF Boosts Bad HFrEF Outcomes
    New-Onset AF Boosts Bad HFrEF OutcomesJune 27, 2020 09:51
  • Join now to see all

Professional Memberships

Hospital Affiliations